Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease

ClinicalTrials.gov ID: NCT01096186

Public ClinicalTrials.gov record NCT01096186. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 3:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the long term safety and clinical utility of IPX066 in subjects with Parkinson's Disease.

Study identification

NCT ID
NCT01096186
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Impax Laboratories, LLC
Industry
Enrollment
617 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2010 (Type not available)
Primary completion
Oct 2011 (Actual)
Completion
Oct 2011 (Actual)
Last update posted
Nov 8, 2019

2010 – 2011

United States locations

U.S. sites
36
U.S. states
21
U.S. cities
33
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
Mohammed Ali Parkinson's Center Phoenix Arizona 85013 —
HOPE Research Institute Phoenix Arizona 85050 —
Clinical Trials Inc. Little Rock Arkansas 72205 —
Coastal Neurological Medical Group La Jolla California 92037 —
Coordinated Clinical Research La Jolla California 92037 —
The Parkinson's Institute Sunnyvale California 94085 —
Collaborative NeuroScience Network, Inc. Torrance California 90502 —
Bradenton Research Center, Inc. Bradenton Florida 34205 —
Sunrise Clinical Research Hollywood Florida 33021 —
Renstar Medical Research Ocala Florida 34471 —
Charlotte Neurological Services Parkinson's Disease Treatment Center of S.W. Florida Port Charlotte Florida 33980 —
Suncoast Neuroscience Associates, Inc. St. Petersburg Florida 33713 —
University of South Florida, Parkinson's Disease and Movement Disorders Center Tampa Florida 33603 —
Medical College of Georgia, Movements Disorders Clinic Augusta Georgia 30912 —
Movement Disorder Center at Idaho Elks Rehabilitation Hospital Boise Idaho 83702 —
Northwestern University, Feinberg School of Medicine, Dept. of Neurology Chicago Illinois 60611 —
Rush University Medical Center Chicago Illinois 60612 —
Iowa Methodist Medical Center Des Moines Iowa 50309 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Quest Research Institute Bingham Farms Michigan 48025 —
Struthers Parkinson's Center Golden Valley Minnesota 55427 —
UMDNJ Robert Wood Johnson Medical Center, Department of Neurology New Brunswick New Jersey 08901 —
Albany Medical College, Parkinson's Disease and Movement Disorders Center Albany New York 12208 —
David L. Kreitzman, MD, P.C. Commack New York 11725 —
Columbia University Neurological Institute New York New York 10032 —
Institute for Human Performance Syracuse New York 13210 —
Duke University Medical Center Movement Disorders Center Durham North Carolina 27707 —
University Neurology, Inc. Cincinnati Ohio 45219 —
University of Toledo Toledo Ohio 43614 —
The Movement Disorder Clinic of Oklahoma Tulsa Oklahoma 74136 —
Medical University of South Carolina Charleston South Carolina 29401 —
University of Texas Southwestern Medical Center Dallas Texas 75390-9184 —
Baylor College of Medicine Houston Texas 77030 —
South Puget Sound Neurology Tacoma Washington 98405 —
Wisconsin Institute for Neurologic and Sleep Disorders Milwaukee Wisconsin 53233 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01096186, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 8, 2019 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01096186 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →